Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.
Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are more cheap and sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 2, 2021 | Seed | — | 1 | — | — | Detail |
Jul 1, 2019 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gaingels | — | Seed |
NJF Capital | — | Seed |